Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
单克隆CD38抗体felzartamab治疗晚期抗体介导的肾移植排斥反应的安全性、耐受性和有效性:一项II期试验的研究方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-022-06198-9
Mayer, Katharina A; Budde, Klemens; Halloran, Philip F; Doberer, Konstantin; Rostaing, Lionel; Eskandary, Farsad; Christamentl, Anna; Wahrmann, Markus; Regele, Heinz; Schranz, Sabine; Ely, Sarah; Firbas, Christa; Schörgenhofer, Christian; Kainz, Alexander; Loupy, Alexandre; Härtle, Stefan; Boxhammer, Rainer; Jilma, Bernd; Böhmig, Georg A